Table 3- Trials relating to podophyllotoxin

 

Reference

Patients

Design

Clearance

Recurrence

Lacey et al 200313

 

358

Randomized controlled

Compares podophyllotoxin solution, podophyllotoxin cream, and podophyllin. Podophyllotoxin showed greater efficacy and cost effectiveness than clinic based treatment with podophyllin.

No data

Tyring S et al, 1998 15

326

Double-blind, randomized trial

After 8 weeks, 64% treated with 0.5% podofilox gel were cleared versus 12% in the vehicle-treated group. The 0.5% podofilox gel was generally well tolerated, with predominantly mild or moderate local reactions

No data

Claesson et al 1996 16

 

Randomized prospective study

 

 

Compared podophyllotoxin cream 0.15% and 0.3% versus 0.5% solution, showing no statistically significant differences between the 3 treatments with regard to both efficacy and safety.

No data

Bonnez W, et al, 1994 17

103

Randomized Controlled Trial

Showing efficacy and tolerance of 0.5% podofilox in the treatment of anogenital warts.

Podophyllotoxin is superior when patient-administered  over the vehicle alone as prophylaxis against recurrence of lesions.